Immune System Diseases
📧 Sign up to get email alerts when something new happens for Immune System Diseases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-01-29Clinical Trial Update: Retroviral Insertion Site Methodology Study [Phase 4]
A Phase 4 clinical trial investigating retroviral insertion site methodology for immune system diseases was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-04-21Clinical Trial Update: A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 3]
A Phase 3 trial combining Zilovertamab with Ibrutinib for relapsed or refractory mantle cell lymphoma has been withdrawn.